Issuer: Immunic, Inc. / Key word(s): Miscellaneous Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need 09.02.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Host Virtu.
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,.
Greetings at the start of Advent to the European Alliance for Personalised Medicine (EAPM) update. It was the first day of December yesterday (1 December), so the festive season is gathering pace, but EAPM is as busy as ever, and it was a busy November, with EAPM in the European Parliament hosting an event as well […]
Good afternoon, and welcome to the European Alliance for Personalised Medicine (EAPM) update – we hope you are all enjoying a good start to the week. All our news items below will be tracked by EAPM at EU and country level, writes EAPM Executive Director Dr. Denis Horgan. Pharma legislation delayed It’s one of the hottest […]
Greetings everyone! Registration for our upcoming Autumn EU Presidency conference is still open which will be a ‘virtual’ event, held online, on Wednesday 10 November, writes European Alliance for Personalised Medicine (EAPM) Executive Director Denis Horgan. Presidency Regulatory health Conference, Wednesday, 10 NovemberThis event will be the third Presidency conference that EAPM will be holding […]